Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- SIG -13.4%, DG -8.5%, DLTR -7.3%, HPQ -5.6%, JKS -5.6%, SBGL -5.5%, EURN -4.4%
- SHLD -4.1%, MOV -4.1%, FLWS -1.1%, ORPN -1.1%, TECD -0.8%
Other news:
- XGTI -8.9% (files for ~833.3K share common stock offering by selling shareholders)
- CRC -4% (light volume - S&P downgrades California Resources Corp. to 'SD')
- REN -2% (light volume, announces that Nicholas J. Sutton will retire as CEO, Richard F. Betz Named Successor CEO Effective January 1, 2017)
- MNTA -1.6% (following late strength on Copaxone ruling; Mylan confirms invalidates two of Teva's Copaxone 40 mg/mL Patents Via U.S. Patent and Trademark Office's Inter Partes Review proceeding)
Analyst comments:
- INFN -3.9% (downgraded to Sell from Neutral at Citigroup)
- OZM -3% (downgraded to Sell from Neutral at Citigroup)
- S -1.5% (downgraded to Underperform from Neutral at Buckingham Research)
- EXPR -0.6% (downgraded to Sell from Neutral at UBS)